Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
Search results for: Affordable Care Act
Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do
Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure
The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market
With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases
Generic Colchicine Approved for Gout Prophylaxis
The cost for therapeautic gout treatment may soon go down, thanks to a recent court ruling
HealthKit Wellness App Holds Promise for Medicine, Rheumatology
Apple’s mobile healthcare technology may benefit patients with rheumatic disease whose conditions require regular monitoring
Update on Legislation, Advocacy Efforts to Advance Rheumatology
Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress
Rheumatologists on the Move
Awards, appointments and announcements in the world of rheumatology
Rheumatology Research Foundation Grant Supports Medical School Curriculum Study
Funding aimed at teaching future physicians, rheumatologists clinical decision-making skills
The American College of Rheumatology Helps Keep Three Biologics Off the SAD List
In October, the Centers for Medicare and Medicaid Services directed carriers to again include three biologics in Medicare Part B coverage. (posted Nov. 19)
Rheum with a View: How Should We Train Rheumatology Fellows?
Regulatory mandates in the ACGME’s Next Accreditation System aim to improve the way rheumatologists are trained, but they might not have the desired effect